News Archive of Burrill Report

ArticleAdded
What Transparency Means for Healthcare05-09-13
Spate of Life Science IPOs Ready to Debut05-07-13
Healthcare Spending Projections May Be Overstated by $770B05-07-13
Celgene Strikes A Deal with Concert05-07-13
The May 2013 Issue of The Burrill Report05-03-13
Regulus CEO Praises JOBS Act05-03-13
New Hormone Holds Promise for Diabetics05-03-13
Natera Lands $54.6 Million to Tranform Pre-Natal Testing05-03-13
Atlas Ventures Closes $265 Million Fund05-03-13
Merck and Pfizer Collaborate on Diabetes Drug05-03-13
Capital Royalty Raises $805 Million Fund05-03-13
Aveo and Astellas Trial Fails to Impress Advisory Panel05-03-13
European Court Enjoins EMA from Releasing AbbVie, InterMune Data05-03-13
Ambrx Strikes Deal with Bristol-Myers for ADC Technology05-03-13
Why Gene Therapy Is Coming of Age05-02-13
Doctors Worldwide Call for Lower Cancer Drug Prices04-25-13
GSK Teams with Avalon to Fund San Diego Biotechs04-26-13
Ocera Therapeutics Going Public in Merger with Tranzyme04-26-13
Vaccine Makers Face Global Challenges04-26-13
Novartis Faces Federal Claims of Kickbacks in Civil Court04-26-13
Theravance Splitting in Two 04-26-13
Global Biotech Survey Highlights Romania, United Arab Emirates04-26-13
AstraZeneca Makes a String of Early-Stage Deals04-26-13
AstraZeneca Makes String of Early-Stage Deals04-24-13
Bill Introduced to Require Labeling of Genetically Engineered Foods04-26-13
Why Biotechs Need to Adapt to the Value-Based World04-23-13
Incentives Reward Surgical Complications04-19-13
Allecra Debuts with $19.5 Million in Funding04-19-13
FDA Won?t Approve Generic Oxycontin04-19-13
Supreme Court Hears Oral Arguments in Myriad case04-19-13
Royalty Pharma Moves to Acquire Elan04-19-13
Celltrion Drops Late-Stage Trial of Roche Rituxan Drug Copy04-18-13
Thermo Fisher Acquires Life Tech for $13.6B04-19-13
U.S. Regulators Lag European Counterparts in Protecting Patients, Report Says04-18-13
Back to that Same Old Place04-18-13
Chimerix and Omthera Go Public in Upsized Offerings04-12-13
Lilly Seeks Savings in Salesforce Cuts04-10-13
GSK Offers $1 Million Prize for Brain Breakthroughs04-11-13
Precision Medicine Meets Antibiotics04-11-13
Seeking Drug Savings, But Risking Safety04-11-13
Obama Budget Raises Ire of PhRMA, BIO04-11-13
Practice Makes Perfect04-10-13
GSK Trial Shows Encouraging Results for Duchenne MD04-10-13
Inovio and U.S. Army Receive $3.5 Million Biodefense Grant04-10-13
VistaGen Secures $36 Million04-10-13
CDC, BARDA Enlist Venter Institute to Combat H7N9 04-10-13
Gene Mutation Could Direct Prostate Cancer Care04-10-13
GSK Strikes Emerging Markets Deal with A*STAR04-09-13
Gene Therapy Startup Raises $41 Million04-08-13
Roche and Isis in $392M Antisense deal for Huntington's Disease04-08-13
Bristol-Myers Replacing R&D Chief04-08-13
Tumor Resistance Genes Can Be Detected Early04-08-13
Appeals Court Rules Against Pfizer in Neurontin Case04-05-13
Teva and Lonza Review Biosimilars Joint Venture04-05-13
Scientists Find New Application for Cholesterol Drug04-05-13
Exits Scarce for Venture Backed Companies in Q104-05-13
NICE Branches into Social Care Standards04-05-13
U.S. Trade Representative Reviewing India's Denial of Glivec Patent04-05-13
Astellas Enters into $300M Cancer Collaboration with Ambrx04-04-13
NIH Launches Brain Research Initiative04-04-13
The JOBS Act One Year Later04-04-13
Gleevec Ruling Is a Blow to Global Public Health04-02-13
Health Insurers Seeking More for Their Dollars03-29-13
Hundreds of clinical trials abandoned after CRO files for bankruptcy03-29-13
Third Rock Ventures Raises $516 Million for New Biotech Fund03-29-13
Edison Pharma Signs $545M Deal with Dainippon Sumitomo03-29-13
Medical Residents Can?t Win03-29-13
Ziopharm Shares Tank on Trial Failure03-29-13
Expanding Research on Highly Toxic Agents Concerns Government Accounting Office03-28-13
Lundbeck Enters Potential $825 Million Deal for Alzheimer's Drug03-29-13
The April 2013 Issue of The Burrill Report03-28-13
SCOTUS Weighs Pay-for-Delay 03-28-13
RARE Webinar: Understanding Drug Development03-25-13
Two Life Sciences IPOs Debut03-22-13
President Obama Outlines $2B Energy Security Trust03-22-13
Feds Ponder Role of Kids in Biodefense Trials03-22-13
One in Three U.S. Seniors Die with Dementia03-22-13
Spanish Researchers Identify Key Mutation in CLL03-22-13
AstraZeneca Slashes R&D, Sales Jobs in Consolidation03-22-13
Sanofi and Biogen get EU Nod on MS Drugs03-22-13
Affymax Eliminates 75 Percent of Staff, Considers Sale or Bankruptcy03-22-13
Wyden Open Spaces03-22-13
Will Regulation Dampen Digital Health Innovation03-21-13
High Profile Pay Cuts Reflect Move to Pay-For Performance03-15-13
Initiative Expanded to Advance Translational Research03-15-13
U.K. Regulator Finds Man Guilty of Falsifying Preclinical Data03-15-13
FDA Proposes to Lower Bar for New Alzheimer's Drugs03-15-13
Application of Nanoparticles Moves From Lab to Field03-15-13
Shire Acquires Premacure03-14-13
Drug Companies Sue EMA over Trials Data03-15-13
PhRMA Cheers Progress in Biotech03-15-13
Why VC Investment in Emerging Markets Is a Demand Problem03-14-13
The March 2013 Issue of The Burrill Report03-12-13
Jury Orders J&J to Pay Plaintiff $8.3 Million for Defective Hip Implant03-08-13
Study Finds Potential Risk in EHR Adoption03-08-13
Device Tax Concerns Expand to Smartphones03-08-13
Basis Science Raises $11.5 M for Health-Tracking Wristwatch03-08-13
China to Reform Food and Drug Safety Oversight03-08-13
New Initiative Takes on Multiple Sclerosis with Big Data03-08-13
U.S. Spending on Traditional Prescription Drugs Fell in 201203-08-13
Aggressive Treatment Halts HIV Infection in Newborn03-08-13
A Proof-of-Concept for Fast Exit Strategy03-08-13
Mylan to Pay $1.6 Billion for Strides Injectables Business03-01-13
Royalty Pharma Offers to Acquire Elan for $6.55 Billion03-01-13
FDA Approves New Breast Cancer Therapy03-01-13
Mylan to Pay $1.6 Billion for Strides Arcolab's Injectables Business03-01-13
Affymax and Takeda Recall Anemia Drug After Three Patients Died03-01-13
Research Advocates Sound Alarm on NIH Sequestration Hit03-01-13
India Weighs Price Controls versus Compulsory Licensing03-01-13
Practice Fusion Buys Startup App Developer03-01-13
OECD Calls for Harmonized Governance of Clinical Trials03-01-13
Supreme Court Hears Monsanto Patent Case02-28-13
Personal Information May Be Released from U.K. Sequencing Effort02-22-13
Supreme Court Hears Monsanto Seed Case02-22-13
Merck and Samsung Bioepis to Develop Biosimilars Together02-22-13
Roche and Chiasma Collaborate on Rare Disease Drug02-22-13
New $3 Million Breakthrough Prize Seeks to Elevate Scientists02-22-13
Lab-grown Ear Matches the Real Thing02-22-13
New U.K. Grant Program Taps Wisdom of Crowds02-21-13
Fox Chase Partners to Personalize Cancer Care02-21-13
Forever Young02-21-13
Cardinal Health to Buy AssuraMed for $2 Billion02-15-13
U.S. Government Recovers Record $4.2 Billion Lost to Fraud02-15-13
The Computer Will See You Now02-15-13
Speedy Approval May Await Breakthrough Therapies02-15-13
Teva Faces $2.1 Billion in Damages For Jumping Gun on Protonix02-15-13
IOM Calls for Reckoning on Cancer Costs02-15-13
Industry Braces for Sequestration02-15-13
BMS Licenses Over-the-Counter Brands to Reckitt for Latin America02-15-13
StemCells Reports Encouraging Trial Results02-15-13
Disruptive Delivery02-15-13
Public-Private Partnership to Spur EU Innovation02-08-13
Proteomics Research Gets a Boost02-08-13
GSK Plans European Cuts02-08-13
EU Drugmakers Enter Public-Private Partnership to Spur Innovation02-08-13
Protalix Biotherapeutics, an Acquisition Target, Retains Citigroup02-08-13
FDA Upgrades Ventilator Recall02-08-13
The Medicines Company Acquires Rights to Alnylam Cholesterol Drug02-08-13
Biogen Buys Tysabri Rights for $3.25 Billion02-08-13
Senators Reignite Fight to Block Pay-for-Delay02-08-13
Early Communications Fueling Success at FDA02-08-13
Pharma's Growing Talent Gap02-08-13
Europe to Invest $1.4 Billion To Create Detailed Brain Model02-01-13
Ben Venue Laboratories Ordered to Stop Operations02-01-13
The Lean Biotech Startup02-01-13
Partnerships Moves Canadian Innovation Forward01-31-13
Trial Results Boost Keryx01-31-13
The February 2013 Issue of The Burrill Report02-01-13
Zoetis IPO Raises $2.24 Billion02-01-13
GlaxoSmithKine to Create New Vaccine with Indian Partner02-01-13
Takeda Wins Diabetes Approvals02-01-13
Seeking a New Approach to Migraines 02-01-13
LipoScience Raises $45 Million in IPO01-25-13
Allegan to Buy MAP Pharmaceuticals for Nearly $1 billion01-25-13
Translational Research Goes Global01-24-13
Novartis Under Investigation on Multiple Fronts01-24-13
Reviews Measure Impact of Mobile Health Tech01-24-13
Smartphones Not Smart in Catching Melanomas01-24-13
Brazil Places $294 Million Bet on Next-Gen Biofuels 01-25-13
California's Stem Cell Agency Seeks to Quell Criticism on Conflicts01-25-13
Deep Brain Stimulation Trial Gets Underway01-25-13
Repairing What's Broken01-24-13
AstraZeneca and Vanderbilt Collaborate on Brain Disorders01-18-13
Big Pharma's Reputation Sinks with Patient Groups01-18-13
FDA Green-lights Neuralstem Trial01-18-13
BMS Moves to Wrap Up Litigation Over Failed Trial01-18-13
Court Ruling Creates Liability for Branded Drugmakers01-18-13
Facing an Adherence and Compliance Gap01-17-13
U.S. Public Biotechs Raise $1.2 Billion in Equity and Debt01-18-13
Generic HIV Treatment Could Save $1 Billion Annually01-18-13
Boosting Venture Capital in Canada01-18-13
Optum Labs Research Center Open for Business01-18-13
Just What the Doctor Ordered01-17-13
Illumina Acquires Verinata for $450 Million01-11-13
Cancer Deaths and Rates in the U.S. Continue to Decline01-11-13
MacroGenics Signs Potential $1 Billion Deal with Gilead Sciences01-11-13
FCC Lines Up $400 Million Annually for Telehealth01-11-13
Agbiotech Startup Gets Funding01-11-13
Flu Bug Putting Strain on Tamiflu Supply01-11-13
BioTime Picks Up Geron's Stem Cell Assets01-11-13
FDA Awards Vertex Breakthrough Designations01-11-13
Tufts Sees Promise in Open Innovation01-11-13
California's Biomedical Industry Shows Resilience01-11-13
Sarepta Adored While Anthera Suffers01-04-13
IPOs Keep Pace01-03-13
San Francisco Adds Three Biotech Startups in New Year 01-03-13
Life Sciences Companies Raise $92.5 Billion in Financings in 2012 01-04-13
A Banner Year for New Drugs01-04-13
Life Sciences M&A Sees Fewer Billion Dollar Deals01-04-13
Discovery and Research Deals Lead Partnering01-04-13
Biogen's ALS Drug Fails Late-Stage Trial 01-03-13
Regenerating Excitement01-04-13
Ode to Healthcare in 201301-03-13
Biotech Visionary G. Steven Burrill Offers Predictions for 2013 12-28-12
Taking Stock: 2012, the JPMorgan Healthcare Conferece, and Beyond 12-28-12
Sutro Biopharma Enters into $500M Deal with Celgene 12-21-12
Amgen Settles Biggest Ever Biotech Off-Label Case12-21-12
Tapping Diverse Pools of Capital12-21-12
Sanofi Lays Foundation for new Industrial Facility in Saudi Arabia12-21-12
The January 2013 Issue of The Burrill Report12-21-12
FDA Guides Industry on How to Tailor Trials12-20-12
Research Spending Creeps Upward12-21-12
Blindness in Type 2 Diabetes Patients Might Be Preventable12-21-12
Biogen Enlists Cell Biologists to Unlock ALS12-21-12
Removing IP Barriers to Innovation12-20-12
Podcast Series: The Virtual Scientific Workplace12-13-12
National Health Service to Map DNA of Up to 100,000 Patients12-14-12
Amgen to Acquire deCODE Genetics for $415 Million12-13-12
EU Leaders Agree on Patent Package12-13-12
FDA Approves Ariad's Cancer Drug Iclusig12-14-12
Gilead to Buy YM BioSciences for $510 Million12-14-12
Teva Looks for $2 Billion in Savings12-13-12
India's Patent Office Revocations Continue12-13-12
Measuring Returns from Innovation12-13-12
The Virtual Scientific Workplace12-07-12
?Pay-for-Delay? Goes to U.S. Supreme Court12-13-12
Antisense Gets Respect12-13-12
Geron Favors Telomerase Target over Blood-Brain-Barrier in Company Restructuring12-07-12
Baxter to Acquire Gambro for $4 Billion12-07-12
Drugmakers and Academia Unite to Create iPS Stem Cell Bank12-07-12
New Estimate of Drug Development Costs Pegs Total at $1.5 Billion12-07-12
$700,000 in Gold Dust Goes Missing from Pfizer Lab12-06-12
Congressman Sees Jobs in Health Tech Boom12-06-12
AliveCor Launches iPhone Heart Monitor12-07-12
Device Makers Partner with FDA to Speed Reviews12-07-12
FDA Touts Its Record on Approvals12-07-12
2020: The New World of Work 12-04-12
GSK Announces $1Billion Expansion in Emerging Market Nutritionals11-30-12
Smith & Nephew Makes $782 Million Push into Wound Care11-30-12
Collaboration Critical to Address Global Health Challenges11-30-12
Roche and the Broad Institute Collaborate to Find New Uses for Abandoned Compounds11-30-12
Selecta Biosciences Strikes Vaccine Partnership with Sanofi11-30-12
Drugmakers Go Prospecting in Québec11-30-12
Branded Drug Prices Rise Sharply in U.S.11-30-12
Novartis Threatens to Pull R&D from the U.K. 11-29-12
Big Pharma Expands Access to Medicines11-30-12
Fiscal Cliff Threatens Life Sciences Industry11-29-12
Stem Cells Ready for Prime Time in Drug Discovery11-29-12
Questioning Values11-21-12
Tiny Bio-bots Show Promise11-21-12
Regular Check-Ups Fail to Extend Life11-21-12
TauRx Lands $112 Million to Fund Alzheimer's Trial11-21-12
Diabetes Cases Soar in the United States11-21-12
Teams Seek Answers in Genomic Data11-21-12
AMA Builds Out Policy Agenda at Meeting11-21-12
Startup Will Map Funders' Microbiomes11-21-12
Fund Manager Targeted for Insider Trades11-21-12
The December 2012 Issue of The Burrill Report11-21-12
Progress Slow in Combating Fake Drugs 11-20-12
No Longer a Working Experiment11-20-12
Compounding Crisis Highlights Gaps in FDA Jurisdiction11-16-12
Mirror, Mirror11-16-12
Intarcia Raises $210 Million to Fund Late Stage Trial11-16-12
Researcher Calls for Roche Boycott11-16-12
FDA Achieves Small Win as Whistleblower Law Passed11-15-12
QB3's Grandest Experiment Pays Off 11-13-12
Roche Seeks Insurance Policy for the Chinese Market11-13-12
Roche Seeks Insurance Policy for the Chinese Market11-13-12
Intarcia Raises $210 Million to Fund Late Stage Trial11-16-12
Researcher Calls for Roche Boycott11-16-12
FDA Achieves Small Win as Whistleblower Law Passed11-15-12
QB3's Grandest Experiment Pays Off 11-13-12
Progress Slow in Combating Fake Drugs 11-20-12
No Longer a Working Experiment11-20-12
Compounding Crisis Highlights Gaps in FDA Jurisdiction11-16-12
Mirror, Mirror11-16-12
AMA Builds Out Policy Agenda at Meeting11-21-12
Startup Will Map Funders' Microbiomes11-21-12
Fund Manager Targeted for Insider Trades11-21-12
The December 2012 Issue of The Burrill Report11-21-12
Regular Check-Ups Fail to Extend Life11-21-12
TauRx Lands $112 Million to Fund Alzheimer's Trial11-21-12
Diabetes Cases Soar in the United States11-21-12
Teams Seek Answers in Genomic Data11-21-12
Stem Cells Ready for Prime Time in Drug Discovery11-29-12
Questioning Values11-21-12
Tiny Bio-bots Show Promise11-21-12
Researcher Calls for Roche Boycott11-16-12
FDA Achieves Small Win as Whistleblower Law Passed11-15-12
QB3's Grandest Experiment Pays Off 11-13-12
Roche Seeks Insurance Policy for the Chinese Market11-13-12
Progress Slow in Combating Fake Drugs 11-20-12
No Longer a Working Experiment11-20-12
Compounding Crisis Highlights Gaps in FDA Jurisdiction11-16-12
Mirror, Mirror11-16-12
Intarcia Raises $210 Million to Fund Late Stage Trial11-16-12
AMA Builds Out Policy Agenda at Meeting11-21-12
Startup Will Map Funders' Microbiomes11-21-12
Fund Manager Targeted for Insider Trades11-21-12
The December 2012 Issue of The Burrill Report11-21-12
Tiny Bio-bots Show Promise11-21-12
Regular Check-Ups Fail to Extend Life11-21-12
TauRx Lands $112 Million to Fund Alzheimer's Trial11-21-12
Diabetes Cases Soar in the United States11-21-12
Teams Seek Answers in Genomic Data11-21-12
Stem Cells Ready for Prime Time in Drug Discovery11-29-12
Questioning Values11-21-12
Outlook for Small Biotech Remains Difficult10-12-12
Two Biotech IPOs Raise $145 million10-12-12
OVP Venture Partners Calling It Quits10-12-12
Johnson & Johnson Seeks a Secure Line to Patients10-12-12
Scripps Creates Digital Medicine Program with Qualcomm10-12-12
India and China Heighten Scrutiny of Medical Devices10-12-12
Commission Calls for Genome Privacy Protections10-12-12
UnitedHealth Group to Acquire Brazil's Largest Health Insurer10-11-12
Lilly, Roche Drugs Chosen for Alzheimer's Trial10-12-12
Presidential Ccommission Calls for Whole Genome Sequencing Privacy Protections10-12-12
Open Science and Reinventing Discovery10-11-12
Regulus IPO: Slash Price, Offer More Shares10-04-12
FDA Says Teva Generic Antidepressant Falls Short10-05-12
UPMC Promotes Personalized Medicine with Big Data Initiative10-04-12
Breast Cancer Study Points to Personalized Treatments10-05-12
J&J Snags Rights to Astellas Drug for up to $945 Million10-05-12
Medtech Ready to Outshine Pharma10-05-12
FDA Defibrillator Approval Triggers Payday10-04-12
NantWorks Delivers High-Speed Genomics Platform10-04-12
Roche's T-DM1 Shines in Breast Cancer Trial10-04-12
Economist Pitches Megafund to Fight Cancer10-04-12
Sanofi Cuts Staff in R&D Reshuffle09-28-12
Medtronic Agrees to Pay $816M for China Kanghui Holdings09-28-12
Drugmakers Paid Feds and States $6.6 Billion in First Half of 201209-28-12
Presidential Science Advisor Plan Seeks to Double New Drug Approvals09-28-12
FDA Gets New Authority over Trials Data09-28-12
FDA Launches Antibacterial Drugs Task Force09-28-12
Peregrine Shares Plunge on Data Discrepancies09-28-12
Aetna Enlists GNS Healthcare in Metabolic Syndrome Fight09-28-12
MD Anderson Launches $3 Billion Moon Shots Program Against Cancer 09-27-12
Syngenta Pushes into Biologic Pest Control09-20-12
The October 2012 Issue of The Burrill Report09-21-12
Threshold Pharmaceuticals? Cancer Drug Misses Target09-20-12
Johnson & Johnson Plans New Global Innovation Centers09-20-12
Drugmakers Band Together on Challenges09-21-12
Life Technologies to Make Companion Diagnostics for Bristol-Myers Squibb 09-21-12
Vivus Launches U.S. Sales of Obesity Drug09-21-12
Will Biotech Double Life Expectancy?09-18-12
China to Mandate Lower Prices on Select Drugs09-20-12
BGI-Shenzhen to Acquire Complete Genomics for $117.6M09-20-12
MedImmune and WuXi Team Up09-14-12
Drug Pipelines Show Waning Progress, Analysis Says09-14-12
J&J Terminates Trial of Investigational Skin Disorder Drug09-14-12
Venture Financings on the Rebound09-14-12
Tobira Therapeutics Completes Senior Management Team09-14-12
Illumina and Partners Healthcare Ally to Help Docs Interpret Genetic Data09-13-12
Indian High Court Upholds Right to Copy Roche Drug09-14-12
AstraZeneca Strikes Partnership with Broad Institute09-14-12
Geron's Course Correction Hits Rocky Road09-14-12
Opexa's Personalized MS Immunotherapy Returns to Clinic09-15-12
Industry Group Turns to Crowdfunding for Biotech Startups09-06-12
ENCODE Decodes Junk DNA09-07-12
Symphogen Licenses Lead Cancer Drug to Merck KGaA09-07-12
Drugmakers Jockey to Lead Prostate Cancer Market09-07-12
Eli Lilly Suffers another Late-Stage Drug Failure09-07-12
IOM Slams Waste and Dysfunction in U.S. Healthcare09-07-12
India Expanding Drug Price Controls 09-07-12
Valeant to Acquire Medicis for $2.6 Billion09-07-12
BioMotiv Aims to Accelerate Therapeutic Innovation09-07-12
Creating Personalized Medicine Bit by Bit09-07-12
Genmab Scores in $1.1 Billion Licensing Deal with J&J08-31-12
Protecting Sustainable Innovation08-31-12
AstraZeneca Appoints New CEO08-30-12
Roche Cancer Drug Meets Primary Trial Endpoint08-30-12
FDA Halts Idenix's Second Hepatitis C Drug 08-31-12
HHS Finalizes New Electronic Health Records Rule08-31-12
Federal Funding of Stem Cell Research Stands08-31-12
FDA Approves Gilead's 4-in-1 HIV Pill 08-30-12
Delaying Tumors08-31-12
Alnylam Plants Its RNAi Technology with Monsanto08-30-12
China Set to Increase Number of Drugs Subject to Price Controls 08-23-12
BMS Backs out of Crowded Hepatitis C Race08-24-12
China Clones Two GM Calves08-23-12
Partnering for Health08-24-12
Allergan and Molecular Partners Enter $1.4 Billion Alliance 08-24-12
Stanford Teams with Intel on Diagnostics08-24-12
Sanofi Pulls Campath to Protect Value of New MS Drug08-24-12
NICE Appeals Process Overhaul in the Works08-24-12
Trial Seeks to Use Stem Cells to Treat Autism08-24-12
Feeling Love for Orphans08-24-12
The September 2012 Issue of The Burrill Report08-22-12
The September 2012 Issue of The Burrill Report08-22-12
Elan to Shed Drug Discovery Unit08-16-12
RNA Therapeutics in the Dealmaking Spotlight 08-16-12
Pfizer's Animal Health Unit Zoetis Files IPO08-17-12
Inching Closer to a Pill for Men08-17-12
Whistleblower Sues Genentech08-16-12
Tengion Fights to Survive08-16-12
Putting Academic Research to the Test08-17-12
Myriad Appeal Is DeJa Vu All Over Again08-17-12
PatientsLikeMe Collaborates with Merck08-17-12
Idenix Hep C Drug Put on Hold over Safety Concerns08-17-12
PatientsLikeMe Forms Health Data Collaboration with Merck08-17-12
Innovation Bank Proposed08-09-12
China Invests in U.K. Diagnostics Startup08-09-12
Alzheimer's Drug Bapineuzumab Fails in Second Trial 08-09-12
Nanobiotix teams up with PharmaEngine in Nanomedicine Deal08-10-12
Pharma Heads Back to School08-09-12
Personalizing Pain Medications08-09-12
As Drugmakers Turn to Global Trials, Politicians Seek Greater Transparency08-09-12
Targeted Drugs Show Less Serious Side Effects 08-09-12
Novartis and UPenn Strike Strategic Partnership08-09-12
U.K. Drug Pricing Talks Approach08-09-12
Bioethics Commission Readies Privacy Advice08-02-12
Customized Therapy08-03-12
Biorenewables Companies Make Headway08-02-12
Globus Medical Prices IPO at $12 per Share08-03-12
Bristol-Myers Bet on Hepatitis C Drug Takes Major Hit08-01-12
Roche CEO Bullish on China08-01-12
Regulate Me08-02-12
Proteus Gains FDA Clearance for Ingestible Sensor08-02-12
Generics Saved $1 Trillion over Past 10 Years08-02-12
Dendreon Cuts Jobs as It Battles Weak Sales 08-02-12
India Preparing to Introduce Price Controls07-27-12
Amarin Wins FDA Approval of Vascepa07-27-12
Hyperion Therapeutics Goes Public07-27-12
Supreme Court Ruling on Healthcare Reform Will Lower Costs07-27-12
California's Stem Cell Agency Approves $150 Million Grants07-27-12
NIH and DARPA Fund Development of Organ-on-a-Chip Systems07-27-12
Fresenius Kabi Plans to Acquire Fenwal07-26-12
NIH and DARPA Fund Development of Tissue Chips for Drug Screening07-27-12
Amarin Announces FDA Approval of Vascepa07-27-12
Blackstone invests $125 Million in NantPharma07-27-12
NEA Reveals $2.6 Billion Global Venture Fund07-27-12
Building a Better Cancer Drug07-27-12
Alzheimer's Drug Fails Late-Stage Trial07-26-12
The August 2012 Issue of The Burrill Report07-24-12
Tools Companies Expand in Diagnostics07-20-12
FDA approves Onyx Multiple Myeloma Drug07-20-12
First Gene Therapy Gets EU Backing07-20-12
MedImmune to Cut 200 Jobs in California07-20-12
Confidence Shaken07-20-12
Durata Therapeutics Becomes Second Completed IPO in Month07-20-12
Human Genome Sciences and GlaxoSmithKline End Hostilities07-19-12
Senator Turns Heat Up on FDA in Spying Scandal07-18-12
Vivus? Obesity Drug Gains FDA Approval07-18-12
Senator Says FDA Spying on Whistleblowers was Authorized 07-18-12
AstraZeneca Ramping up Virtual Neuroscience Effort 07-13-12
Chelsea Therapeutics' CEO Steps Down07-13-12
Clinical Trials Waste Billions of Dollars Through Unnecessary Procedures07-13-12
23andMe Acquires CureTogether07-13-12
The Already-Approved Drug Researchers Think Can Combat Aging07-12-12
Biolex Files for Bankruptcy07-12-12
Complete Genomics Says Tech Sets Standard for Clinical Grade Genomes07-12-12
Janssen and Evotec Partner on Portfolio of Diabetes Drugs07-12-12
Obama Signs User Fee Bill07-10-12
Cells From Parkinson's Patients Show Unique Drug Responses 07-06-12
GSK to Pay $3 Billion to Settle Civil and Criminal Charges with U.S. and States07-06-12
Pfizer Grants Russia's SatRx Rights to Diabetes Compound07-05-12
BMS to Acquire Amylin for $5.3 Billion Plus Debt07-06-12
Sanofi May Slash 2,000 Jobs in France07-06-12
FDA proposes ID system for medical devices07-06-12
USPTO Official Attacks Compulsory License07-06-12
First Rapid Over-the-Counter HIV Test Approved in U.S.07-06-12
NIH Targets $275M for Rare Disease Research07-06-12
Rare Disease Community Scores a Big Victory07-06-12
Idec and Isis Pharmaceuticals in Rare Disease Pact06-29-12
New Mobile Healthcare Survey Reveals Mixed Bag06-29-12
Making NICE with Investors06-29-12
FDA Approves Arena's Obesity Drug06-29-12
India Proposes Offering Generic Drugs for Free06-29-12
Digital Health VC Financing Booms in Year's First Half06-29-12
User Fee Bill Awaits President's Signature06-29-12
Supreme Court Upholds Healthcare Reform06-29-12
Roche to Shed 1,000 Jobs in New Jersey06-29-12
Overhauling R&D with Nothing but Net 06-29-12
Celgene Withdraws EU Application for Revlimid06-22-12
Celgene Withdraws EU Application for Revlimed06-22-12
BGI and Hospital Plan to Sequence 1,000 Rare Diseases06-22-12
BIO Study: Bayh-Dole Shows Big Returns06-22-12
The Biotech Story You Won?t Read in your Local Newspaper06-22-12
User Fee Bill Passes the House06-22-12
India Unveils Plans for Reviewing Biosimilars06-22-12
Alzheimer's Disease Fight Heats Up06-22-12
Ambrx Lands $303M Deal to Make Improved Drugs06-22-12
Drugmakers Pledge $1.8M to Advance Neuroscience Research06-23-12
Seeing a Silver Lining to Big Pharma's Patent Cliff06-21-12
The July 2012 Issue of The Burrill Report06-15-12
Mapping the Single Cell World06-15-12
A Gentleman's D for Mitt06-15-12
Startups raise $786 million in June's First Half06-15-12
A Drug by Any Other Name06-15-12
BSN Medical Acquired by EQT in $2.5 Billion Deal06-15-12
Computer Model Predicts Drug Side Effects06-15-12
Children of Older Fathers May Live Longer Than Most06-15-12
Johnson & Johnson Reaches $2.2 Billion Settlement with Government over Marketing Probes06-15-12
Genentech's Big Bet on New Cancer Drugs06-15-12
A Pitch to Employees06-14-12
California Smoking Tax Vote Outcome Too Close to Call06-08-12
D? Bomb06-08-12
Astellas and Drais Partner to Launch Virtual Company06-08-12
Dr. Reddy's and Merck Serono Partner on Biosimilars06-08-12
Chelsea Execs Take Pay Cuts Amid Troubles06-08-12
HHS and West Wireless Partner to Kickstart Health App Development06-08-12
Why Dendreon May Have Felt Less Pain at ASCO than Expected06-07-12
U.S. Third Worst among 12 Developed Countries for Value-Based Healthcare06-08-12
Complete Genomics Restructures, Seeks Strategic Alternatives06-08-12
Phone Appointments Effective in Battling Depression06-07-12
Marina Biotech Slashes 90 Percent of Workforce05-31-12
Bristol-Myers Squibb Forms the International Immuno-Oncology Network05-31-12
23andMe Patent Creates Concerns with Customers06-01-12
China Poised to Boost Biotech06-01-12
User Fee Packages Win Congressional Approval06-01-12